Next Stage One: Accelerating Animal Health Biologics: Technologies and Case Studies from Cell line to Manufacture

Speed and scalability are critical for success in animal health biologics. Dr. Zhou Hang, Senior Vice President, Head of BioProcess Research and Development Department of WuXi Biologics, shares how the company leverages CHO platforms, single-use technologies, and digital tools to reduce timelines and costs while ensuring global regulatory compliance. Real-world examples illustrate how these innovations enable rapid commercialization, strengthen supply chains, and support sustainable growth in the veterinary biologics market.